Pharma & Healthcare
Global Tumor Ablation Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 06, 25
- ID: 291610
- Pages: 137
- Figures: 131
- Views: 40
In 2024, the global market size of Tumor Ablation was estimated to be worth US$ 655 million and is forecast to reach approximately US$ 1304 million by 2031 with a CAGR of 10.5% during the forecast period 2025-2031.
This is a minimally invasive surgical method to treat solid cancers, Special probes are used to “burn” or “freeze” cancers without the usual surgery. Computed Tomography (CT), Ultrasound (US) or Magnetic Resonance Imaging (MRI) is used to guide and position the needle probe into the tumor. This requires only a tiny hole, usually less than 3 mm via which the probe is introduced. When the probe is within the cancer it is attached to a generator which “burns” or “freezes” the cancer. In this report, we only study the Tumor Ablation devices without Consumables.
Global Tumor Ablation key players include Chongqing Haifu Medical, HealthTronics, AngioDynamics, Boston Scientific, Medtronic, etc. Global top five manufacturers hold a share about 55%.
North America is the largest market, with a share about 40%, followed by Europe, with a share about 30 percent. In terms of product, Radiofrequency (RF) Ablation is the largest segment, with a share about 40%. And in terms of application, the largest application is Lung Cancer, followed by Liver Cancer, Kidney Cancer, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tumor Ablation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Ablation.
The Tumor Ablation market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tumor Ablation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tumor Ablation manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Angiodynamics
Medtronic
Boston Scientific
Misonix
Sonacare Medical
EDAP TMS
Chongqing Haifu Medical
HealthTronics
J &J
Segment by Type
Radiofrequency (RF) Ablation
Microwave Ablation
Cryoablation
Other Technologies
Segment by Application
Liver Cancer
Lung Cancer
Kidney Cancer
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Tumor Ablation in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Tumor Ablation manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tumor Ablation sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
This is a minimally invasive surgical method to treat solid cancers, Special probes are used to “burn” or “freeze” cancers without the usual surgery. Computed Tomography (CT), Ultrasound (US) or Magnetic Resonance Imaging (MRI) is used to guide and position the needle probe into the tumor. This requires only a tiny hole, usually less than 3 mm via which the probe is introduced. When the probe is within the cancer it is attached to a generator which “burns” or “freezes” the cancer. In this report, we only study the Tumor Ablation devices without Consumables.
Global Tumor Ablation key players include Chongqing Haifu Medical, HealthTronics, AngioDynamics, Boston Scientific, Medtronic, etc. Global top five manufacturers hold a share about 55%.
North America is the largest market, with a share about 40%, followed by Europe, with a share about 30 percent. In terms of product, Radiofrequency (RF) Ablation is the largest segment, with a share about 40%. And in terms of application, the largest application is Lung Cancer, followed by Liver Cancer, Kidney Cancer, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tumor Ablation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Ablation.
The Tumor Ablation market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tumor Ablation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tumor Ablation manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Angiodynamics
Medtronic
Boston Scientific
Misonix
Sonacare Medical
EDAP TMS
Chongqing Haifu Medical
HealthTronics
J &J
Segment by Type
Radiofrequency (RF) Ablation
Microwave Ablation
Cryoablation
Other Technologies
Segment by Application
Liver Cancer
Lung Cancer
Kidney Cancer
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Tumor Ablation in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Tumor Ablation manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tumor Ablation sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
1 Study Coverage
1.1 Tumor Ablation Product Introduction
1.2 Market by Type
1.2.1 Global Tumor Ablation Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Radiofrequency (RF) Ablation
1.2.3 Microwave Ablation
1.2.4 Cryoablation
1.2.5 Other Technologies
1.3 Market by Application
1.3.1 Global Tumor Ablation Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Liver Cancer
1.3.3 Lung Cancer
1.3.4 Kidney Cancer
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Tumor Ablation Market Size Estimates and Forecasts
2.1.1 Global Tumor Ablation Revenue 2020-2031
2.1.2 Global Tumor Ablation Sales 2020-2031
2.2 Tumor Ablation Market Size by Region: 2024 Versus 2031
2.3 Tumor Ablation Sales by Region (2020-2031)
2.3.1 Global Tumor Ablation Sales by Region: 2020-2025
2.3.2 Global Tumor Ablation Sales Forecast by Region (2026-2031)
2.3.3 Global Tumor Ablation Sales Market Share by Region (2020-2031)
2.4 Tumor Ablation Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Tumor Ablation Revenue by Region: 2020-2025
2.4.2 Global Tumor Ablation Revenue Forecast by Region (2026-2031)
2.4.3 Global Tumor Ablation Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Tumor Ablation Sales by Type (2020-2031)
3.1.1.1 Global Tumor Ablation Sales Volume by Type (2020-2031)
3.1.1.2 Global Tumor Ablation Sales Market Share by Type (2020-2031)
3.1.2 Global Tumor Ablation Revenue by Type (2020-2031)
3.1.2.1 Global Tumor Ablation Revenue by Type (2020-2031)
3.1.2.2 Global Tumor Ablation Revenue Market Share by Type (2020-2031)
3.1.3 Tumor Ablation Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Tumor Ablation Sales by Application (2020-2031)
3.2.1.1 Global Tumor Ablation Sales Volume by Application (2020-2031)
3.2.1.2 Global Tumor Ablation Sales Market Share by Application (2020-2031)
3.2.2 Global Tumor Ablation Revenue by Application (2020-2031)
3.2.2.1 Global Tumor Ablation Revenue by Application (2020-2031)
3.2.2.2 Global Tumor Ablation Revenue Market Share by Application (2020-2031)
3.2.3 Tumor Ablation Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Radiofrequency (RF) Ablation of Tumor Ablation Revenue Market Share by Application
3.3.2 Microwave Ablation of Tumor Ablation Revenue Market Share by Application
3.3.3 Cryoablation of Tumor Ablation Revenue Market Share by Application
3.3.4 Other Technologies of Tumor Ablation Revenue Market Share by Application
4 Global Tumor Ablation by Manufacturers
4.1 Global Top Tumor Ablation Manufacturers by Sales (2020-2025)
4.1.1 Global Tumor Ablation Sales by Manufacturer (2020-2025)
4.1.2 Global Tumor Ablation Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Tumor Ablation Manufacturers by Revenue (2020-2025)
4.2.1 Global Tumor Ablation Revenue by Manufacturer (2020-2025)
4.2.2 Global Tumor Ablation Revenue Share by Manufacturer (2020-2025)
4.3 Global Tumor Ablation Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Tumor Ablation Manufacturers Covered: Ranking by Revenue
4.4.2 Global Tumor Ablation Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Tumor Ablation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Tumor Ablation Manufacturing Base Distribution, Product Type
4.5.1 Tumor Ablation Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Tumor Ablation Market
4.5.3 Manufacturers Tumor Ablation Product Type and Application
4.5.4 Radiofrequency (RF) Ablation Market Sales of Tumor Ablation by Manufacturer
4.5.5 Microwave Ablation Market Sales of Tumor Ablation by Manufacturer
4.5.6 Cryoablation Market Sales of Tumor Ablation by Manufacturer
4.5.7 Other Technologies Market Sales of Tumor Ablation by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Angiodynamics
5.1.1 Angiodynamics Company Information
5.1.2 Angiodynamics Description, Business Overview
5.1.3 Angiodynamics Tumor Ablation Products Offered
5.1.4 Angiodynamics Tumor Ablation Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Angiodynamics Tumor Ablation Sales by Product in 2024
5.1.6 Angiodynamics Tumor Ablation Sales by Application in 2024
5.1.7 Angiodynamics Tumor Ablation Sales by Geographic Area in 2024
5.1.8 Angiodynamics Recent Developments
5.2 Medtronic
5.2.1 Medtronic Company Information
5.2.2 Medtronic Description, Business Overview
5.2.3 Medtronic Tumor Ablation Products Offered
5.2.4 Medtronic Tumor Ablation Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Medtronic Tumor Ablation Sales by Product in 2024
5.2.6 Medtronic Tumor Ablation Sales by Application in 2024
5.2.7 Medtronic Tumor Ablation Sales by Geographic Area in 2024
5.2.8 Medtronic Recent Developments
5.3 Boston Scientific
5.3.1 Boston Scientific Company Information
5.3.2 Boston Scientific Description, Business Overview
5.3.3 Boston Scientific Tumor Ablation Products Offered
5.3.4 Boston Scientific Tumor Ablation Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Boston Scientific Tumor Ablation Sales by Product in 2024
5.3.6 Boston Scientific Tumor Ablation Sales by Application in 2024
5.3.7 Boston Scientific Tumor Ablation Sales by Geographic Area in 2024
5.3.8 Boston Scientific Recent Developments
5.4 Misonix
5.4.1 Misonix Company Information
5.4.2 Misonix Description, Business Overview
5.4.3 Misonix Tumor Ablation Products Offered
5.4.4 Misonix Tumor Ablation Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Misonix Tumor Ablation Sales by Product in 2024
5.4.6 Misonix Tumor Ablation Sales by Application in 2024
5.4.7 Misonix Tumor Ablation Sales by Geographic Area in 2024
5.4.8 Misonix Recent Developments
5.5 Sonacare Medical
5.5.1 Sonacare Medical Company Information
5.5.2 Sonacare Medical Description, Business Overview
5.5.3 Sonacare Medical Tumor Ablation Products Offered
5.5.4 Sonacare Medical Tumor Ablation Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Sonacare Medical Tumor Ablation Sales by Product in 2024
5.5.6 Sonacare Medical Tumor Ablation Sales by Application in 2024
5.5.7 Sonacare Medical Tumor Ablation Sales by Geographic Area in 2024
5.5.8 Sonacare Medical Recent Developments
5.6 EDAP TMS
5.6.1 EDAP TMS Company Information
5.6.2 EDAP TMS Description, Business Overview
5.6.3 EDAP TMS Tumor Ablation Products Offered
5.6.4 EDAP TMS Tumor Ablation Sales, Revenue and Gross Margin (2020-2025)
5.6.5 EDAP TMS Tumor Ablation Sales by Product in 2024
5.6.6 EDAP TMS Tumor Ablation Sales by Application in 2024
5.6.7 EDAP TMS Tumor Ablation Sales by Geographic Area in 2024
5.6.8 EDAP TMS Recent Developments
5.7 Chongqing Haifu Medical
5.7.1 Chongqing Haifu Medical Company Information
5.7.2 Chongqing Haifu Medical Description, Business Overview
5.7.3 Chongqing Haifu Medical Tumor Ablation Products Offered
5.7.4 Chongqing Haifu Medical Tumor Ablation Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Chongqing Haifu Medical Tumor Ablation Sales by Product in 2024
5.7.6 Chongqing Haifu Medical Tumor Ablation Sales by Application in 2024
5.7.7 Chongqing Haifu Medical Tumor Ablation Sales by Geographic Area in 2024
5.7.8 Chongqing Haifu Medical Recent Developments
5.8 HealthTronics
5.8.1 HealthTronics Company Information
5.8.2 HealthTronics Description, Business Overview
5.8.3 HealthTronics Tumor Ablation Products Offered
5.8.4 HealthTronics Tumor Ablation Sales, Revenue and Gross Margin (2020-2025)
5.8.5 HealthTronics Tumor Ablation Sales by Product in 2024
5.8.6 HealthTronics Tumor Ablation Sales by Application in 2024
5.8.7 HealthTronics Tumor Ablation Sales by Geographic Area in 2024
5.8.8 HealthTronics Recent Developments
5.9 J &J
5.9.1 J &J Company Information
5.9.2 J &J Description, Business Overview
5.9.3 J &J Tumor Ablation Products Offered
5.9.4 J &J Tumor Ablation Sales, Revenue and Gross Margin (2020-2025)
5.9.5 J &J Tumor Ablation Sales by Product in 2024
5.9.6 J &J Tumor Ablation Sales by Application in 2024
5.9.7 J &J Tumor Ablation Sales by Geographic Area in 2024
5.9.8 J &J Recent Developments
6 North America
6.1 North America Tumor Ablation Market Size YoY Growth 2020-2031
6.2 North America Tumor Ablation Market Facts & Figures by Country
6.2.1 North America Tumor Ablation Sales by Country (2020-2031)
6.2.2 North America Tumor Ablation Revenue by Country (2020-2031)
6.3 North America Tumor Ablation Sales by Type (2020-2025)
6.4 North America Tumor Ablation Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Tumor Ablation Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Tumor Ablation Market Facts & Figures by Region
7.2.1 Asia-Pacific Tumor Ablation Sales by Region (2020-2031)
7.2.2 Asia-Pacific Tumor Ablation Revenue by Region (2020-2031)
7.3 Asia-Pacific Tumor Ablation Sales by Type (2020-2025)
7.4 Asia-Pacific Tumor Ablation Sales by Application (2020-2025)
8 Europe
8.1 Europe Tumor Ablation Market Size YoY Growth 2020-2031
8.2 Europe Tumor Ablation Market Facts & Figures by Country
8.2.1 Europe Tumor Ablation Sales by Country (2020-2031)
8.2.2 Europe Tumor Ablation Revenue by Country (2020-2031)
8.3 Europe Tumor Ablation Sales by Type (2020-2025)
8.4 Europe Tumor Ablation Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Tumor Ablation Market Size YoY Growth 2020-2031
9.2 Latin America Tumor Ablation Market Facts & Figures by Country
9.2.1 Latin America Tumor Ablation Sales by Country (2020-2031)
9.2.2 Latin America Tumor Ablation Revenue by Country (2020-2031)
9.3 Latin America Tumor Ablation Sales by Type (2020-2025)
9.4 Latin America Tumor Ablation Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Tumor Ablation Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Tumor Ablation Market Facts & Figures by Country
10.2.1 Middle East and Africa Tumor Ablation Sales by Country (2020-2031)
10.2.2 Middle East and Africa Tumor Ablation Revenue by Country (2020-2031)
10.3 Middle East and Africa Tumor Ablation Sales by Type (2020-2025)
10.4 Middle East and Africa Tumor Ablation Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Tumor Ablation Supply Chain Analysis
11.2 Tumor Ablation Key Raw Materials and Upstream Suppliers
11.3 Tumor Ablation Clients Analysis
11.4 Tumor Ablation Sales Channel and Sales Model Analysis
11.4.1 Tumor Ablation Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Tumor Ablation Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Tumor Ablation Distributors
12 Tumor Ablation Market Dynamics
12.1 Tumor Ablation Industry Trends
12.2 Tumor Ablation Market Drivers
12.3 Tumor Ablation Market Challenges
12.4 Tumor Ablation Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Tumor Ablation Product Introduction
1.2 Market by Type
1.2.1 Global Tumor Ablation Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Radiofrequency (RF) Ablation
1.2.3 Microwave Ablation
1.2.4 Cryoablation
1.2.5 Other Technologies
1.3 Market by Application
1.3.1 Global Tumor Ablation Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Liver Cancer
1.3.3 Lung Cancer
1.3.4 Kidney Cancer
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Tumor Ablation Market Size Estimates and Forecasts
2.1.1 Global Tumor Ablation Revenue 2020-2031
2.1.2 Global Tumor Ablation Sales 2020-2031
2.2 Tumor Ablation Market Size by Region: 2024 Versus 2031
2.3 Tumor Ablation Sales by Region (2020-2031)
2.3.1 Global Tumor Ablation Sales by Region: 2020-2025
2.3.2 Global Tumor Ablation Sales Forecast by Region (2026-2031)
2.3.3 Global Tumor Ablation Sales Market Share by Region (2020-2031)
2.4 Tumor Ablation Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Tumor Ablation Revenue by Region: 2020-2025
2.4.2 Global Tumor Ablation Revenue Forecast by Region (2026-2031)
2.4.3 Global Tumor Ablation Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Tumor Ablation Sales by Type (2020-2031)
3.1.1.1 Global Tumor Ablation Sales Volume by Type (2020-2031)
3.1.1.2 Global Tumor Ablation Sales Market Share by Type (2020-2031)
3.1.2 Global Tumor Ablation Revenue by Type (2020-2031)
3.1.2.1 Global Tumor Ablation Revenue by Type (2020-2031)
3.1.2.2 Global Tumor Ablation Revenue Market Share by Type (2020-2031)
3.1.3 Tumor Ablation Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Tumor Ablation Sales by Application (2020-2031)
3.2.1.1 Global Tumor Ablation Sales Volume by Application (2020-2031)
3.2.1.2 Global Tumor Ablation Sales Market Share by Application (2020-2031)
3.2.2 Global Tumor Ablation Revenue by Application (2020-2031)
3.2.2.1 Global Tumor Ablation Revenue by Application (2020-2031)
3.2.2.2 Global Tumor Ablation Revenue Market Share by Application (2020-2031)
3.2.3 Tumor Ablation Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Radiofrequency (RF) Ablation of Tumor Ablation Revenue Market Share by Application
3.3.2 Microwave Ablation of Tumor Ablation Revenue Market Share by Application
3.3.3 Cryoablation of Tumor Ablation Revenue Market Share by Application
3.3.4 Other Technologies of Tumor Ablation Revenue Market Share by Application
4 Global Tumor Ablation by Manufacturers
4.1 Global Top Tumor Ablation Manufacturers by Sales (2020-2025)
4.1.1 Global Tumor Ablation Sales by Manufacturer (2020-2025)
4.1.2 Global Tumor Ablation Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Tumor Ablation Manufacturers by Revenue (2020-2025)
4.2.1 Global Tumor Ablation Revenue by Manufacturer (2020-2025)
4.2.2 Global Tumor Ablation Revenue Share by Manufacturer (2020-2025)
4.3 Global Tumor Ablation Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Tumor Ablation Manufacturers Covered: Ranking by Revenue
4.4.2 Global Tumor Ablation Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Tumor Ablation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Tumor Ablation Manufacturing Base Distribution, Product Type
4.5.1 Tumor Ablation Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Tumor Ablation Market
4.5.3 Manufacturers Tumor Ablation Product Type and Application
4.5.4 Radiofrequency (RF) Ablation Market Sales of Tumor Ablation by Manufacturer
4.5.5 Microwave Ablation Market Sales of Tumor Ablation by Manufacturer
4.5.6 Cryoablation Market Sales of Tumor Ablation by Manufacturer
4.5.7 Other Technologies Market Sales of Tumor Ablation by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Angiodynamics
5.1.1 Angiodynamics Company Information
5.1.2 Angiodynamics Description, Business Overview
5.1.3 Angiodynamics Tumor Ablation Products Offered
5.1.4 Angiodynamics Tumor Ablation Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Angiodynamics Tumor Ablation Sales by Product in 2024
5.1.6 Angiodynamics Tumor Ablation Sales by Application in 2024
5.1.7 Angiodynamics Tumor Ablation Sales by Geographic Area in 2024
5.1.8 Angiodynamics Recent Developments
5.2 Medtronic
5.2.1 Medtronic Company Information
5.2.2 Medtronic Description, Business Overview
5.2.3 Medtronic Tumor Ablation Products Offered
5.2.4 Medtronic Tumor Ablation Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Medtronic Tumor Ablation Sales by Product in 2024
5.2.6 Medtronic Tumor Ablation Sales by Application in 2024
5.2.7 Medtronic Tumor Ablation Sales by Geographic Area in 2024
5.2.8 Medtronic Recent Developments
5.3 Boston Scientific
5.3.1 Boston Scientific Company Information
5.3.2 Boston Scientific Description, Business Overview
5.3.3 Boston Scientific Tumor Ablation Products Offered
5.3.4 Boston Scientific Tumor Ablation Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Boston Scientific Tumor Ablation Sales by Product in 2024
5.3.6 Boston Scientific Tumor Ablation Sales by Application in 2024
5.3.7 Boston Scientific Tumor Ablation Sales by Geographic Area in 2024
5.3.8 Boston Scientific Recent Developments
5.4 Misonix
5.4.1 Misonix Company Information
5.4.2 Misonix Description, Business Overview
5.4.3 Misonix Tumor Ablation Products Offered
5.4.4 Misonix Tumor Ablation Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Misonix Tumor Ablation Sales by Product in 2024
5.4.6 Misonix Tumor Ablation Sales by Application in 2024
5.4.7 Misonix Tumor Ablation Sales by Geographic Area in 2024
5.4.8 Misonix Recent Developments
5.5 Sonacare Medical
5.5.1 Sonacare Medical Company Information
5.5.2 Sonacare Medical Description, Business Overview
5.5.3 Sonacare Medical Tumor Ablation Products Offered
5.5.4 Sonacare Medical Tumor Ablation Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Sonacare Medical Tumor Ablation Sales by Product in 2024
5.5.6 Sonacare Medical Tumor Ablation Sales by Application in 2024
5.5.7 Sonacare Medical Tumor Ablation Sales by Geographic Area in 2024
5.5.8 Sonacare Medical Recent Developments
5.6 EDAP TMS
5.6.1 EDAP TMS Company Information
5.6.2 EDAP TMS Description, Business Overview
5.6.3 EDAP TMS Tumor Ablation Products Offered
5.6.4 EDAP TMS Tumor Ablation Sales, Revenue and Gross Margin (2020-2025)
5.6.5 EDAP TMS Tumor Ablation Sales by Product in 2024
5.6.6 EDAP TMS Tumor Ablation Sales by Application in 2024
5.6.7 EDAP TMS Tumor Ablation Sales by Geographic Area in 2024
5.6.8 EDAP TMS Recent Developments
5.7 Chongqing Haifu Medical
5.7.1 Chongqing Haifu Medical Company Information
5.7.2 Chongqing Haifu Medical Description, Business Overview
5.7.3 Chongqing Haifu Medical Tumor Ablation Products Offered
5.7.4 Chongqing Haifu Medical Tumor Ablation Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Chongqing Haifu Medical Tumor Ablation Sales by Product in 2024
5.7.6 Chongqing Haifu Medical Tumor Ablation Sales by Application in 2024
5.7.7 Chongqing Haifu Medical Tumor Ablation Sales by Geographic Area in 2024
5.7.8 Chongqing Haifu Medical Recent Developments
5.8 HealthTronics
5.8.1 HealthTronics Company Information
5.8.2 HealthTronics Description, Business Overview
5.8.3 HealthTronics Tumor Ablation Products Offered
5.8.4 HealthTronics Tumor Ablation Sales, Revenue and Gross Margin (2020-2025)
5.8.5 HealthTronics Tumor Ablation Sales by Product in 2024
5.8.6 HealthTronics Tumor Ablation Sales by Application in 2024
5.8.7 HealthTronics Tumor Ablation Sales by Geographic Area in 2024
5.8.8 HealthTronics Recent Developments
5.9 J &J
5.9.1 J &J Company Information
5.9.2 J &J Description, Business Overview
5.9.3 J &J Tumor Ablation Products Offered
5.9.4 J &J Tumor Ablation Sales, Revenue and Gross Margin (2020-2025)
5.9.5 J &J Tumor Ablation Sales by Product in 2024
5.9.6 J &J Tumor Ablation Sales by Application in 2024
5.9.7 J &J Tumor Ablation Sales by Geographic Area in 2024
5.9.8 J &J Recent Developments
6 North America
6.1 North America Tumor Ablation Market Size YoY Growth 2020-2031
6.2 North America Tumor Ablation Market Facts & Figures by Country
6.2.1 North America Tumor Ablation Sales by Country (2020-2031)
6.2.2 North America Tumor Ablation Revenue by Country (2020-2031)
6.3 North America Tumor Ablation Sales by Type (2020-2025)
6.4 North America Tumor Ablation Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Tumor Ablation Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Tumor Ablation Market Facts & Figures by Region
7.2.1 Asia-Pacific Tumor Ablation Sales by Region (2020-2031)
7.2.2 Asia-Pacific Tumor Ablation Revenue by Region (2020-2031)
7.3 Asia-Pacific Tumor Ablation Sales by Type (2020-2025)
7.4 Asia-Pacific Tumor Ablation Sales by Application (2020-2025)
8 Europe
8.1 Europe Tumor Ablation Market Size YoY Growth 2020-2031
8.2 Europe Tumor Ablation Market Facts & Figures by Country
8.2.1 Europe Tumor Ablation Sales by Country (2020-2031)
8.2.2 Europe Tumor Ablation Revenue by Country (2020-2031)
8.3 Europe Tumor Ablation Sales by Type (2020-2025)
8.4 Europe Tumor Ablation Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Tumor Ablation Market Size YoY Growth 2020-2031
9.2 Latin America Tumor Ablation Market Facts & Figures by Country
9.2.1 Latin America Tumor Ablation Sales by Country (2020-2031)
9.2.2 Latin America Tumor Ablation Revenue by Country (2020-2031)
9.3 Latin America Tumor Ablation Sales by Type (2020-2025)
9.4 Latin America Tumor Ablation Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Tumor Ablation Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Tumor Ablation Market Facts & Figures by Country
10.2.1 Middle East and Africa Tumor Ablation Sales by Country (2020-2031)
10.2.2 Middle East and Africa Tumor Ablation Revenue by Country (2020-2031)
10.3 Middle East and Africa Tumor Ablation Sales by Type (2020-2025)
10.4 Middle East and Africa Tumor Ablation Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Tumor Ablation Supply Chain Analysis
11.2 Tumor Ablation Key Raw Materials and Upstream Suppliers
11.3 Tumor Ablation Clients Analysis
11.4 Tumor Ablation Sales Channel and Sales Model Analysis
11.4.1 Tumor Ablation Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Tumor Ablation Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Tumor Ablation Distributors
12 Tumor Ablation Market Dynamics
12.1 Tumor Ablation Industry Trends
12.2 Tumor Ablation Market Drivers
12.3 Tumor Ablation Market Challenges
12.4 Tumor Ablation Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Tumor Ablation Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Tumor Ablation Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Tumor Ablation Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Tumor Ablation Sales by Region (2020-2025) & (K Units)
Table 5. Global Tumor Ablation Sales Forecast by Region (2026-2031) & (K Units)
Table 6. Global Tumor Ablation Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Tumor Ablation Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Tumor Ablation Sales Volume by Type (2020-2025) & (K Units)
Table 9. Global Tumor Ablation Sales Volume by Type (2026-2031) & (K Units)
Table 10. Global Tumor Ablation Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Tumor Ablation Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Tumor Ablation Sales Volume by Application (2020-2025) & (K Units)
Table 13. Global Tumor Ablation Sales Volume by Application (2026-2031) & (K Units)
Table 14. Global Tumor Ablation Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Tumor Ablation Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Tumor Ablation Sales by Manufacturer (2020-2025) & (K Units)
Table 17. Global Tumor Ablation Sales Share by Manufacturer (2020-2025)
Table 18. Tumor Ablation Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Tumor Ablation Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Tumor Ablation Price (2020-2025) & (USD/Unit)
Table 21. Ranking of Global Top Tumor Ablation Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Tumor Ablation Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Tumor Ablation by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Ablation as of 2024)
Table 24. Tumor Ablation Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Tumor Ablation Market
Table 26. Manufacturers Tumor Ablation Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Angiodynamics Company Information
Table 29. Angiodynamics Description and Business Overview
Table 30. Angiodynamics Tumor Ablation Product
Table 31. Angiodynamics Tumor Ablation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 32. Angiodynamics Sales Proportion of Tumor Ablation by Product in 2024
Table 33. Angiodynamics Sales Proportion of Tumor Ablation by Application in 2024
Table 34. Angiodynamics Sales Proportion of Tumor Ablation by Geographic Area in 2024
Table 35. Angiodynamics Recent Developments
Table 36. Medtronic Company Information
Table 37. Medtronic Description and Business Overview
Table 38. Medtronic Tumor Ablation Product
Table 39. Medtronic Tumor Ablation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 40. Medtronic Sales Proportion of Tumor Ablation by Product in 2024
Table 41. Medtronic Sales Proportion of Tumor Ablation by Application in 2024
Table 42. Medtronic Sales Proportion of Tumor Ablation by Geographic Area in 2024
Table 43. Medtronic Recent Developments
Table 44. Boston Scientific Company Information
Table 45. Boston Scientific Description and Business Overview
Table 46. Boston Scientific Tumor Ablation Product
Table 47. Boston Scientific Tumor Ablation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 48. Boston Scientific Sales Proportion of Tumor Ablation by Product in 2024
Table 49. Boston Scientific Sales Proportion of Tumor Ablation by Application in 2024
Table 50. Boston Scientific Sales Proportion of Tumor Ablation by Geographic Area in 2024
Table 51. Boston Scientific Recent Developments
Table 52. Misonix Company Information
Table 53. Misonix Description and Business Overview
Table 54. Misonix Tumor Ablation Product
Table 55. Misonix Tumor Ablation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. Misonix Sales Proportion of Tumor Ablation by Product in 2024
Table 57. Misonix Sales Proportion of Tumor Ablation by Application in 2024
Table 58. Misonix Sales Proportion of Tumor Ablation by Geographic Area in 2024
Table 59. Misonix Recent Developments
Table 60. Sonacare Medical Company Information
Table 61. Sonacare Medical Description and Business Overview
Table 62. Sonacare Medical Tumor Ablation Product
Table 63. Sonacare Medical Tumor Ablation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Sonacare Medical Sales Proportion of Tumor Ablation by Product in 2024
Table 65. Sonacare Medical Sales Proportion of Tumor Ablation by Application in 2024
Table 66. Sonacare Medical Sales Proportion of Tumor Ablation by Geographic Area in 2024
Table 67. Sonacare Medical Recent Developments
Table 68. EDAP TMS Company Information
Table 69. EDAP TMS Description and Business Overview
Table 70. EDAP TMS Tumor Ablation Product
Table 71. EDAP TMS Tumor Ablation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 72. EDAP TMS Sales Proportion of Tumor Ablation by Product in 2024
Table 73. EDAP TMS Sales Proportion of Tumor Ablation by Application in 2024
Table 74. EDAP TMS Sales Proportion of Tumor Ablation by Geographic Area in 2024
Table 75. EDAP TMS Recent Developments
Table 76. Chongqing Haifu Medical Company Information
Table 77. Chongqing Haifu Medical Description and Business Overview
Table 78. Chongqing Haifu Medical Tumor Ablation Product
Table 79. Chongqing Haifu Medical Tumor Ablation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Chongqing Haifu Medical Sales Proportion of Tumor Ablation by Product in 2024
Table 81. Chongqing Haifu Medical Sales Proportion of Tumor Ablation by Application in 2024
Table 82. Chongqing Haifu Medical Sales Proportion of Tumor Ablation by Geographic Area in 2024
Table 83. Chongqing Haifu Medical Recent Developments
Table 84. HealthTronics Company Information
Table 85. HealthTronics Description and Business Overview
Table 86. HealthTronics Tumor Ablation Product
Table 87. HealthTronics Tumor Ablation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. HealthTronics Sales Proportion of Tumor Ablation by Product in 2024
Table 89. HealthTronics Sales Proportion of Tumor Ablation by Application in 2024
Table 90. HealthTronics Sales Proportion of Tumor Ablation by Geographic Area in 2024
Table 91. HealthTronics Recent Developments
Table 92. J &J Company Information
Table 93. J &J Description and Business Overview
Table 94. J &J Tumor Ablation Product
Table 95. J &J Tumor Ablation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. J &J Sales Proportion of Tumor Ablation by Product in 2024
Table 97. J &J Sales Proportion of Tumor Ablation by Application in 2024
Table 98. J &J Sales Proportion of Tumor Ablation by Geographic Area in 2024
Table 99. J &J Recent Developments
Table 100. North America Tumor Ablation Sales by Country (2020-2025) & (K Units)
Table 101. North America Tumor Ablation Sales by Country (2026-2031) & (K Units)
Table 102. North America Tumor Ablation Revenue by Country (2020-2025) & (US$ Million)
Table 103. North America Tumor Ablation Revenue by Country (2026-2031) & (US$ Million)
Table 104. North America Tumor Ablation Sales by Type (2020-2025) & (K Units)
Table 105. North America Tumor Ablation Sales by Application (2020-2025) & (K Units)
Table 106. Asia-Pacific Tumor Ablation Sales by Region (2020-2025) & (K Units)
Table 107. Asia-Pacific Tumor Ablation Sales by Region (2026-2031) & (K Units)
Table 108. Asia-Pacific Tumor Ablation Revenue by Region (2020-2025) & (US$ Million)
Table 109. Asia-Pacific Tumor Ablation Revenue by Region (2026-2031) & (US$ Million)
Table 110. Asia-Pacific Tumor Ablation Sales by Type (2020-2025) & (K Units)
Table 111. Asia-Pacific Tumor Ablation Sales by Application (2020-2025) & (K Units)
Table 112. Europe Tumor Ablation Sales by Country (2020-2025) & (K Units)
Table 113. Europe Tumor Ablation Sales by Country (2026-2031) & (K Units)
Table 114. Europe Tumor Ablation Revenue by Country (2020-2025) & (US$ Million)
Table 115. Europe Tumor Ablation Revenue by Country (2026-2031) & (US$ Million)
Table 116. Europe Tumor Ablation Sales by Type (2020-2025) & (K Units)
Table 117. Europe Tumor Ablation Sales by Application (2020-2025) & (K Units)
Table 118. Latin America Tumor Ablation Sales by Country (2020-2025) & (K Units)
Table 119. Latin America Tumor Ablation Sales by Country (2026-2031) & (K Units)
Table 120. Latin America Tumor Ablation Revenue by Country (2020-2025) & (US$ Million)
Table 121. Latin America Tumor Ablation Revenue by Country (2026-2031) & (US$ Million)
Table 122. Latin America Tumor Ablation Sales by Type (2020-2025) & (K Units)
Table 123. Latin America Tumor Ablation Sales by Application (2020-2025) & (K Units)
Table 124. Middle East and Africa Tumor Ablation Sales by Country (2020-2025) & (K Units)
Table 125. Middle East and Africa Tumor Ablation Sales by Country (2026-2031) & (K Units)
Table 126. Middle East and Africa Tumor Ablation Revenue by Country (2020-2025) & (US$ Million)
Table 127. Middle East and Africa Tumor Ablation Revenue by Country (2026-2031) & (US$ Million)
Table 128. Middle East and Africa Tumor Ablation Sales by Type (2020-2025) & (K Units)
Table 129. Middle East and Africa Tumor Ablation Sales by Application (2020-2025) & (K Units)
Table 130. Tumor Ablation Key Raw Materials, Industry Status and Trend
Table 131. Tumor Ablation Key Raw Materials and Upstream Suppliers
Table 132. Tumor Ablation Clients Status and Trend
Table 133. Tumor Ablation Typical Clients
Table 134. Tumor Ablation Distributors
Table 135. Tumor Ablation Market Trends
Table 136. Tumor Ablation Market Drivers
Table 137. Tumor Ablation Market Challenges
Table 138. Tumor Ablation Market Restraints
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
Table 142. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Tumor Ablation Product Picture
Figure 2. Global Tumor Ablation Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Tumor Ablation Sales Market Share by Type in 2024 & 2031
Figure 4. Radiofrequency (RF) Ablation Product Picture
Figure 5. Microwave Ablation Product Picture
Figure 6. Cryoablation Product Picture
Figure 7. Other Technologies Product Picture
Figure 8. Global Tumor Ablation Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 9. Global Tumor Ablation Sales Market Share by Application in 2024 & 2031
Figure 10. Liver Cancer
Figure 11. Lung Cancer
Figure 12. Kidney Cancer
Figure 13. Others
Figure 14. Tumor Ablation Report Years Considered
Figure 15. Global Tumor Ablation Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Tumor Ablation Market Size 2020-2031 (US$ Million)
Figure 17. Global Tumor Ablation Sales 2020-2031 (K Units)
Figure 18. Global Tumor Ablation Sales Market Share Forecast by Region (2020-2031)
Figure 19. Global Tumor Ablation Revenue Market Share by Region (2020-2031)
Figure 20. Global Tumor Ablation Sales Market Share Forecast by Type (2020-2031)
Figure 21. Global Tumor Ablation Revenue Market Share Forecast by Type (2020-2031)
Figure 22. Tumor Ablation Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
Figure 23. Global Tumor Ablation Sales Market Share Forecast by Application (2020-2031)
Figure 24. Global Tumor Ablation Revenue Market Share Forecast by Application (2020-2031)
Figure 25. Tumor Ablation Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
Figure 26. Radiofrequency (RF) Ablation of Tumor Ablation Revenue Market Share by Application, 2024 VS 2031
Figure 27. Microwave Ablation of Tumor Ablation Revenue Market Share by Application, 2024 VS 2031
Figure 28. Cryoablation of Tumor Ablation Revenue Market Share by Application, 2024 VS 2031
Figure 29. Other Technologies of Tumor Ablation Revenue Market Share by Application, 2024 VS 2031
Figure 30. Global Tumor Ablation Sales Share by Manufacturer in 2024
Figure 31. Tumor Ablation Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 32. Radiofrequency (RF) Ablation Market Sales Proportion by Manufacturer in 2024
Figure 33. Microwave Ablation Market Sales Proportion by Manufacturer in 2024
Figure 34. Cryoablation Market Sales Proportion by Manufacturer in 2024
Figure 35. Other Technologies Market Sales Proportion by Manufacturer in 2024
Figure 36. North America Tumor Ablation Revenue 2020-2031 (US$ Million)
Figure 37. North America Tumor Ablation Sales Market Share by Type (2020-2025)
Figure 38. North America Tumor Ablation Sales Market Share by Application (2020-2025)
Figure 39. Asia-Pacific Tumor Ablation Revenue 2020-2031 (US$ Million)
Figure 40. Asia-Pacific Tumor Ablation Sales Market Share by Region (2020-2031)
Figure 41. Asia-Pacific Tumor Ablation Revenue Market Share by Region (2020-2031)
Figure 42. Asia-Pacific Tumor Ablation Sales Market Share by Type (2020-2025)
Figure 43. Asia-Pacific Tumor Ablation Sales Market Share by Application (2020-2025)
Figure 44. Europe Tumor Ablation Revenue Growth Rate 2020-2031 (US$ Million)
Figure 45. Europe Tumor Ablation Sales Market Share by Country (2020-2031)
Figure 46. Europe Tumor Ablation Revenue Market Share by Country (2020-2031)
Figure 47. Europe Tumor Ablation Sales Market Share by Type (2020-2025)
Figure 48. Europe Tumor Ablation Sales Market Share by Application (2020-2025)
Figure 49. Latin America Tumor Ablation Revenue Growth Rate 2020-2031 (US$ Million)
Figure 50. Latin America Tumor Ablation Sales Market Share by Country (2020-2031)
Figure 51. Latin America Tumor Ablation Revenue Market Share by Country (2020-2025)
Figure 52. Latin America Tumor Ablation Sales Market Share by Type (2020-2025)
Figure 53. Latin America Tumor Ablation Sales Market Share by Application (2020-2025)
Figure 54. Middle East and Africa Tumor Ablation Revenue Growth Rate 2020-2031 (US$ Million)
Figure 55. Middle East and Africa Tumor Ablation Sales Market Share by Country (2020-2031)
Figure 56. Middle East and Africa Tumor Ablation Revenue Market Share by Country (2020-2031)
Figure 57. Middle East and Africa Tumor Ablation Sales Market Share by Type (2020-2025)
Figure 58. Middle East and Africa Tumor Ablation Sales Market Share by Application (2020-2025)
Figure 59. Tumor Ablation Supply Chain (Upstream and Downstream Market)
Figure 60. Global Production Market Share of Tumor Ablation Raw Materials by Region in 2024
Figure 61. Tumor Ablation Distribution Channels
Figure 62. Global Tumor Ablation Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 63. Global Tumor Ablation Percentage 2020-2031: Online Sales VS Offline Sales
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Tumor Ablation Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Tumor Ablation Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Tumor Ablation Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Tumor Ablation Sales by Region (2020-2025) & (K Units)
Table 5. Global Tumor Ablation Sales Forecast by Region (2026-2031) & (K Units)
Table 6. Global Tumor Ablation Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Tumor Ablation Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Tumor Ablation Sales Volume by Type (2020-2025) & (K Units)
Table 9. Global Tumor Ablation Sales Volume by Type (2026-2031) & (K Units)
Table 10. Global Tumor Ablation Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Tumor Ablation Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Tumor Ablation Sales Volume by Application (2020-2025) & (K Units)
Table 13. Global Tumor Ablation Sales Volume by Application (2026-2031) & (K Units)
Table 14. Global Tumor Ablation Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Tumor Ablation Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Tumor Ablation Sales by Manufacturer (2020-2025) & (K Units)
Table 17. Global Tumor Ablation Sales Share by Manufacturer (2020-2025)
Table 18. Tumor Ablation Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Tumor Ablation Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Tumor Ablation Price (2020-2025) & (USD/Unit)
Table 21. Ranking of Global Top Tumor Ablation Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Tumor Ablation Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Tumor Ablation by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Ablation as of 2024)
Table 24. Tumor Ablation Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Tumor Ablation Market
Table 26. Manufacturers Tumor Ablation Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Angiodynamics Company Information
Table 29. Angiodynamics Description and Business Overview
Table 30. Angiodynamics Tumor Ablation Product
Table 31. Angiodynamics Tumor Ablation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 32. Angiodynamics Sales Proportion of Tumor Ablation by Product in 2024
Table 33. Angiodynamics Sales Proportion of Tumor Ablation by Application in 2024
Table 34. Angiodynamics Sales Proportion of Tumor Ablation by Geographic Area in 2024
Table 35. Angiodynamics Recent Developments
Table 36. Medtronic Company Information
Table 37. Medtronic Description and Business Overview
Table 38. Medtronic Tumor Ablation Product
Table 39. Medtronic Tumor Ablation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 40. Medtronic Sales Proportion of Tumor Ablation by Product in 2024
Table 41. Medtronic Sales Proportion of Tumor Ablation by Application in 2024
Table 42. Medtronic Sales Proportion of Tumor Ablation by Geographic Area in 2024
Table 43. Medtronic Recent Developments
Table 44. Boston Scientific Company Information
Table 45. Boston Scientific Description and Business Overview
Table 46. Boston Scientific Tumor Ablation Product
Table 47. Boston Scientific Tumor Ablation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 48. Boston Scientific Sales Proportion of Tumor Ablation by Product in 2024
Table 49. Boston Scientific Sales Proportion of Tumor Ablation by Application in 2024
Table 50. Boston Scientific Sales Proportion of Tumor Ablation by Geographic Area in 2024
Table 51. Boston Scientific Recent Developments
Table 52. Misonix Company Information
Table 53. Misonix Description and Business Overview
Table 54. Misonix Tumor Ablation Product
Table 55. Misonix Tumor Ablation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. Misonix Sales Proportion of Tumor Ablation by Product in 2024
Table 57. Misonix Sales Proportion of Tumor Ablation by Application in 2024
Table 58. Misonix Sales Proportion of Tumor Ablation by Geographic Area in 2024
Table 59. Misonix Recent Developments
Table 60. Sonacare Medical Company Information
Table 61. Sonacare Medical Description and Business Overview
Table 62. Sonacare Medical Tumor Ablation Product
Table 63. Sonacare Medical Tumor Ablation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Sonacare Medical Sales Proportion of Tumor Ablation by Product in 2024
Table 65. Sonacare Medical Sales Proportion of Tumor Ablation by Application in 2024
Table 66. Sonacare Medical Sales Proportion of Tumor Ablation by Geographic Area in 2024
Table 67. Sonacare Medical Recent Developments
Table 68. EDAP TMS Company Information
Table 69. EDAP TMS Description and Business Overview
Table 70. EDAP TMS Tumor Ablation Product
Table 71. EDAP TMS Tumor Ablation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 72. EDAP TMS Sales Proportion of Tumor Ablation by Product in 2024
Table 73. EDAP TMS Sales Proportion of Tumor Ablation by Application in 2024
Table 74. EDAP TMS Sales Proportion of Tumor Ablation by Geographic Area in 2024
Table 75. EDAP TMS Recent Developments
Table 76. Chongqing Haifu Medical Company Information
Table 77. Chongqing Haifu Medical Description and Business Overview
Table 78. Chongqing Haifu Medical Tumor Ablation Product
Table 79. Chongqing Haifu Medical Tumor Ablation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Chongqing Haifu Medical Sales Proportion of Tumor Ablation by Product in 2024
Table 81. Chongqing Haifu Medical Sales Proportion of Tumor Ablation by Application in 2024
Table 82. Chongqing Haifu Medical Sales Proportion of Tumor Ablation by Geographic Area in 2024
Table 83. Chongqing Haifu Medical Recent Developments
Table 84. HealthTronics Company Information
Table 85. HealthTronics Description and Business Overview
Table 86. HealthTronics Tumor Ablation Product
Table 87. HealthTronics Tumor Ablation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. HealthTronics Sales Proportion of Tumor Ablation by Product in 2024
Table 89. HealthTronics Sales Proportion of Tumor Ablation by Application in 2024
Table 90. HealthTronics Sales Proportion of Tumor Ablation by Geographic Area in 2024
Table 91. HealthTronics Recent Developments
Table 92. J &J Company Information
Table 93. J &J Description and Business Overview
Table 94. J &J Tumor Ablation Product
Table 95. J &J Tumor Ablation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. J &J Sales Proportion of Tumor Ablation by Product in 2024
Table 97. J &J Sales Proportion of Tumor Ablation by Application in 2024
Table 98. J &J Sales Proportion of Tumor Ablation by Geographic Area in 2024
Table 99. J &J Recent Developments
Table 100. North America Tumor Ablation Sales by Country (2020-2025) & (K Units)
Table 101. North America Tumor Ablation Sales by Country (2026-2031) & (K Units)
Table 102. North America Tumor Ablation Revenue by Country (2020-2025) & (US$ Million)
Table 103. North America Tumor Ablation Revenue by Country (2026-2031) & (US$ Million)
Table 104. North America Tumor Ablation Sales by Type (2020-2025) & (K Units)
Table 105. North America Tumor Ablation Sales by Application (2020-2025) & (K Units)
Table 106. Asia-Pacific Tumor Ablation Sales by Region (2020-2025) & (K Units)
Table 107. Asia-Pacific Tumor Ablation Sales by Region (2026-2031) & (K Units)
Table 108. Asia-Pacific Tumor Ablation Revenue by Region (2020-2025) & (US$ Million)
Table 109. Asia-Pacific Tumor Ablation Revenue by Region (2026-2031) & (US$ Million)
Table 110. Asia-Pacific Tumor Ablation Sales by Type (2020-2025) & (K Units)
Table 111. Asia-Pacific Tumor Ablation Sales by Application (2020-2025) & (K Units)
Table 112. Europe Tumor Ablation Sales by Country (2020-2025) & (K Units)
Table 113. Europe Tumor Ablation Sales by Country (2026-2031) & (K Units)
Table 114. Europe Tumor Ablation Revenue by Country (2020-2025) & (US$ Million)
Table 115. Europe Tumor Ablation Revenue by Country (2026-2031) & (US$ Million)
Table 116. Europe Tumor Ablation Sales by Type (2020-2025) & (K Units)
Table 117. Europe Tumor Ablation Sales by Application (2020-2025) & (K Units)
Table 118. Latin America Tumor Ablation Sales by Country (2020-2025) & (K Units)
Table 119. Latin America Tumor Ablation Sales by Country (2026-2031) & (K Units)
Table 120. Latin America Tumor Ablation Revenue by Country (2020-2025) & (US$ Million)
Table 121. Latin America Tumor Ablation Revenue by Country (2026-2031) & (US$ Million)
Table 122. Latin America Tumor Ablation Sales by Type (2020-2025) & (K Units)
Table 123. Latin America Tumor Ablation Sales by Application (2020-2025) & (K Units)
Table 124. Middle East and Africa Tumor Ablation Sales by Country (2020-2025) & (K Units)
Table 125. Middle East and Africa Tumor Ablation Sales by Country (2026-2031) & (K Units)
Table 126. Middle East and Africa Tumor Ablation Revenue by Country (2020-2025) & (US$ Million)
Table 127. Middle East and Africa Tumor Ablation Revenue by Country (2026-2031) & (US$ Million)
Table 128. Middle East and Africa Tumor Ablation Sales by Type (2020-2025) & (K Units)
Table 129. Middle East and Africa Tumor Ablation Sales by Application (2020-2025) & (K Units)
Table 130. Tumor Ablation Key Raw Materials, Industry Status and Trend
Table 131. Tumor Ablation Key Raw Materials and Upstream Suppliers
Table 132. Tumor Ablation Clients Status and Trend
Table 133. Tumor Ablation Typical Clients
Table 134. Tumor Ablation Distributors
Table 135. Tumor Ablation Market Trends
Table 136. Tumor Ablation Market Drivers
Table 137. Tumor Ablation Market Challenges
Table 138. Tumor Ablation Market Restraints
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
Table 142. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Tumor Ablation Product Picture
Figure 2. Global Tumor Ablation Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Tumor Ablation Sales Market Share by Type in 2024 & 2031
Figure 4. Radiofrequency (RF) Ablation Product Picture
Figure 5. Microwave Ablation Product Picture
Figure 6. Cryoablation Product Picture
Figure 7. Other Technologies Product Picture
Figure 8. Global Tumor Ablation Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 9. Global Tumor Ablation Sales Market Share by Application in 2024 & 2031
Figure 10. Liver Cancer
Figure 11. Lung Cancer
Figure 12. Kidney Cancer
Figure 13. Others
Figure 14. Tumor Ablation Report Years Considered
Figure 15. Global Tumor Ablation Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Tumor Ablation Market Size 2020-2031 (US$ Million)
Figure 17. Global Tumor Ablation Sales 2020-2031 (K Units)
Figure 18. Global Tumor Ablation Sales Market Share Forecast by Region (2020-2031)
Figure 19. Global Tumor Ablation Revenue Market Share by Region (2020-2031)
Figure 20. Global Tumor Ablation Sales Market Share Forecast by Type (2020-2031)
Figure 21. Global Tumor Ablation Revenue Market Share Forecast by Type (2020-2031)
Figure 22. Tumor Ablation Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
Figure 23. Global Tumor Ablation Sales Market Share Forecast by Application (2020-2031)
Figure 24. Global Tumor Ablation Revenue Market Share Forecast by Application (2020-2031)
Figure 25. Tumor Ablation Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
Figure 26. Radiofrequency (RF) Ablation of Tumor Ablation Revenue Market Share by Application, 2024 VS 2031
Figure 27. Microwave Ablation of Tumor Ablation Revenue Market Share by Application, 2024 VS 2031
Figure 28. Cryoablation of Tumor Ablation Revenue Market Share by Application, 2024 VS 2031
Figure 29. Other Technologies of Tumor Ablation Revenue Market Share by Application, 2024 VS 2031
Figure 30. Global Tumor Ablation Sales Share by Manufacturer in 2024
Figure 31. Tumor Ablation Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 32. Radiofrequency (RF) Ablation Market Sales Proportion by Manufacturer in 2024
Figure 33. Microwave Ablation Market Sales Proportion by Manufacturer in 2024
Figure 34. Cryoablation Market Sales Proportion by Manufacturer in 2024
Figure 35. Other Technologies Market Sales Proportion by Manufacturer in 2024
Figure 36. North America Tumor Ablation Revenue 2020-2031 (US$ Million)
Figure 37. North America Tumor Ablation Sales Market Share by Type (2020-2025)
Figure 38. North America Tumor Ablation Sales Market Share by Application (2020-2025)
Figure 39. Asia-Pacific Tumor Ablation Revenue 2020-2031 (US$ Million)
Figure 40. Asia-Pacific Tumor Ablation Sales Market Share by Region (2020-2031)
Figure 41. Asia-Pacific Tumor Ablation Revenue Market Share by Region (2020-2031)
Figure 42. Asia-Pacific Tumor Ablation Sales Market Share by Type (2020-2025)
Figure 43. Asia-Pacific Tumor Ablation Sales Market Share by Application (2020-2025)
Figure 44. Europe Tumor Ablation Revenue Growth Rate 2020-2031 (US$ Million)
Figure 45. Europe Tumor Ablation Sales Market Share by Country (2020-2031)
Figure 46. Europe Tumor Ablation Revenue Market Share by Country (2020-2031)
Figure 47. Europe Tumor Ablation Sales Market Share by Type (2020-2025)
Figure 48. Europe Tumor Ablation Sales Market Share by Application (2020-2025)
Figure 49. Latin America Tumor Ablation Revenue Growth Rate 2020-2031 (US$ Million)
Figure 50. Latin America Tumor Ablation Sales Market Share by Country (2020-2031)
Figure 51. Latin America Tumor Ablation Revenue Market Share by Country (2020-2025)
Figure 52. Latin America Tumor Ablation Sales Market Share by Type (2020-2025)
Figure 53. Latin America Tumor Ablation Sales Market Share by Application (2020-2025)
Figure 54. Middle East and Africa Tumor Ablation Revenue Growth Rate 2020-2031 (US$ Million)
Figure 55. Middle East and Africa Tumor Ablation Sales Market Share by Country (2020-2031)
Figure 56. Middle East and Africa Tumor Ablation Revenue Market Share by Country (2020-2031)
Figure 57. Middle East and Africa Tumor Ablation Sales Market Share by Type (2020-2025)
Figure 58. Middle East and Africa Tumor Ablation Sales Market Share by Application (2020-2025)
Figure 59. Tumor Ablation Supply Chain (Upstream and Downstream Market)
Figure 60. Global Production Market Share of Tumor Ablation Raw Materials by Region in 2024
Figure 61. Tumor Ablation Distribution Channels
Figure 62. Global Tumor Ablation Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 63. Global Tumor Ablation Percentage 2020-2031: Online Sales VS Offline Sales
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232